Amyris, Inc. (AMRS)
| Market Cap | 4.47B |
| Revenue (ttm) | 320.87M |
| Net Income (ttm) | -585.80M |
| Shares Out | 267.73M |
| EPS (ttm) | -2.53 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 29 |
| Last Price | $15.11 |
| Previous Close | $15.07 |
| Change ($) | 0.04 |
| Change (%) | 0.27% |
| Day's Open | 15.00 |
| Day's Range | 14.82 - 15.54 |
| Day's Volume | 1,661,317 |
| 52-Week Range | 1.88 - 23.42 |
The indices are on pace to end the week in the green, backed by a 4-day winning streak. Make the most of this market with today's best short plays from Q.ai's deep learning algorithms.
EMERYVILLE, Calif., July 22, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer bran...
EMERYVILLE, Calif., July 21, 2021 /PRNewswire/ -- Amyris, Inc., (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer br...
Shares of AMRS stock are on the move today as retail investors appear to be intrigued by this name, providing buying momentum. The post AMRS Stock: Why Biotech Stock Amyris Is Shooting Higher Today appe...
Markets started off the week right where they left off on Friday, with a sharp pullback at the open. Find opportunities with today's best short plays from Q.ai's artificial intelligence.
The Dow, the S&P 500, and the Nasdaq are all in the red after a morning surge. Find opportunities in this market with today's best short plays from Q.ai's deep learning algorithms.
Thursday marked a lower day on Wall Street with all three indices trading in the red, albeit slightly. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
The S&P 500 is up more than 16% now this year and over 36% in the last 12 months. Make the most of this market with today's best short plays from Q.ai's artificial intelligence.
EMERYVILLE, Calif., July 13, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer bran...
Shares of these overlooked gems could make investors very rich once the rest of the market notices their value.
Markets were well in the red this morning with the S&P off about 1.2%, the Dow lower by about 1%, and the Nasdaq taking the brunt of selling pressure down just under 1.5%. Find opportunities in today's ...
The S&P 500 moved higher this morning, led by tech stocks, as the Nasdaq aimed for another record open. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
EMERYVILLE, Calif., July 1, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a t...
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues t...
EMERYVILLE, Calif., June 17, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today ...
EMERYVILLE, Calif., June 16, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today ...
EMERYVILLE, Calif., June 15, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a ...
EMERYVILLE, Calif., June 2, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today a...
Jobless claims fell to yet another pandemic-era low, and cyclical stocks popped while the rotation out of tech continued for another day. Meanwhile, Q.ai's Artificial Intelligence systems have assessed ...
One of these things is (no longer) like the others.
The Dow Jones rose 70 points, the S&P 500 gained 0.3%, and the Nasdaq climbed 0.6%. Meanwhile, Q.ai's artificial intelligence has assessed each firm to find the best short plays of the day.
Although stocks were deeply in the red in overnight trading, the jobless claims can be credited for the sharp reversal today. Q.ai's artificial intelligence systems assessed each firm to find the best s...
The major indices have all traded in the red. But, if you're looking for a way to play this market, the deep learning algorithms at Q.ai have crunched the data to give you a set of Top Shorts.
EMERYVILLE, Calif., May 18, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a to...
Going into today, the Dow Jones continued its sell-off and fell more than 150 points while the S&P 500 lost 0.6% and the Nasdaq dipped more than 1%. Our AI has identified the following stocks rated To...
EMERYVILLE, Calif., May 11, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today a...
The major indices are trading mixed amid signs that reopening and recovery are on the horizon. If you're looking for a way to play this market, the deep learning algorithms at Q.ai have crunched the dat...
Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -575.00% and 367.23%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
EMERYVILLE, Calif., May 6, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today an...
EMERYVILLE, Calif., May 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier o...
Amyris' (AMRS) Q1 results are likely to have benefited from continued strong growth in its consumer brands.
EMERYVILLE, Calif. and WESTCHESTER, Ill.
Amyris, Inc. (AMRS) closed at $14.56 in the latest trading session, marking a -1.42% move from the prior day.
Amyris, Inc. (AMRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EMERYVILLE, Calif., April 26, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a...
EMERYVILLE, Calif., April 21, 2021 /PRNewswire/ -- Amyris, Inc., (Nasdaq: AMRS) a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a...
EMERYVILLE, Calif., April 15, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...
EMERYVILLE, Calif., April 14, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...
Amyris, Inc. (NASDAQ:AMRS) is a synthetic biotech and renewable chemical company.
Amyris Announces Pricing of a $300.0 Million Public Offering (Secondary and Primary) of Common Stock
EMERYVILLE, Calif., April 9, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer bra...
EMERYVILLE, Calif., April 7, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer bra...
If you check the summary page for Amyris Inc. (NASDAQ:AMRS) at GuruFocus, you'll find a lot of weak metrics. That includes ratings of 1 out of 10 for both financial strength and profitability.
A rebounding economy is a good time to thaw out your risk capital and start buying some high-risk stocks with long-term potential. The post 8 High-Risk Stocks to Buy That Are Worth Taking A Chance On ap...
EMERYVILLE, Calif., April 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a t...
EMERYVILLE, Calif., April 1, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a t...
EMERYVILLE, Calif., March 31, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...
EMERYVILLE, Calif., March 25, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...
TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Amazon and Microsoft
EMERYVILLE, Calif., March 16, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a ...
The market for sustainable personal care products is booming. Amyris, one of the earliest synthetic biology companies, is launching new brands to ride the wave.
About AMRS
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells products for the health and wellness, clean beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Ins... [Read more...]
| Industry Specialty Chemicals | IPO Date Sep 28, 2010 |
| CEO John Melo | Employees 595 |
| Stock Exchange NASDAQ | Ticker Symbol AMRS |
Financial Performance
In 2020, Amyris's revenue was $173.14 million, an increase of 13.49% compared to the previous year's $152.56 million. Losses were -$331.04 million, 36.4% more than in 2019.
Analyst Forecasts
According to 4 analysts, the average rating for Amyris stock is "Strong Buy." The 12-month stock price forecast is 24.00, which is an increase of 58.84% from the latest price.